Medacta Group Management
Management criteria checks 2/4
Medacta Group's CEO is Francesco Siccardi, appointed in Nov 2018, has a tenure of 4.08 years. directly owns 19.75% of the company’s shares, worth $430.56M. The average tenure of the management team and the board of directors is 9.4 years and 3.9 years respectively.
Key information
Francesco Siccardi
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 4.1yrs |
| CEO ownership | 19.8% |
| Management average tenure | 9.4yrs |
| Board average tenure | 3.9yrs |
Recent management updates
No updates
Recent updates
CEO
Francesco Siccardi (45 yo)
4.1yrs
Tenure
Dr. Francesco Siccardi has been Chief Executive Officer of Medacta Group SA since November 1, 2018. He is a Member of the Board of Directors of Surgical Practice Resource Group SA, Lugano since 2015 and of...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Non Executive Chairman | 4.9yrs | no data | 10.12% $ 220.7m | |
| Chief Executive Officer | 4.1yrs | no data | 19.75% $ 430.6m | |
| Chief Financial Officer | 11.9yrs | no data | no data | |
| Senior Director of Global Marketing | no data | no data | no data | |
| HR Director | no data | no data | no data | |
| Supply Chain Director | 6.9yrs | no data | 19.75% $ 430.6m | |
| Secretary of the Board | no data | no data | no data |
9.4yrs
Average Tenure
49.5yo
Average Age
Experienced Management: MEDG.F's management team is seasoned and experienced (9.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Non Executive Chairman | 4.9yrs | no data | 10.12% $ 220.7m | |
| Lead Independent Director | 3.9yrs | no data | 0.0075% $ 163.7k | |
| Independent Director | 2yrs | no data | 0.22% $ 4.7m | |
| Independent Director | 3.8yrs | no data | no data | |
| Non-executive Director | 4.9yrs | no data | 19.75% $ 430.6m |
3.9yrs
Average Tenure
62yo
Average Age
Experienced Board: MEDG.F's board of directors are considered experienced (3.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/12/28 14:33 |
| End of Day Share Price | 2022/09/30 00:00 |
| Earnings | 2022/06/30 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Medacta Group SA is covered by 11 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Samuel England | Berenberg |
| Christoph Gretler | Credit Suisse |
| David Adlington | J.P. Morgan |